Search hospitals > Virginia > Fairfax
Virginia Cancer Specialists
Claim this profileFairfax, Virginia 22031
Global Leader in Non-Small Cell Lung Cancer
Global Leader in Solid Tumors
Conducts research for Tumors
Conducts research for Cancer
Conducts research for Lung Cancer
440 reported clinical trials
18 medical researchers
Summary
Virginia Cancer Specialists is a medical facility located in Fairfax, Virginia. This center is recognized for care of Non-Small Cell Lung Cancer, Solid Tumors, Tumors, Cancer, Lung Cancer and other specialties. Virginia Cancer Specialists is involved with conducting 440 clinical trials across 239 conditions. There are 18 research doctors associated with this hospital, such as Alexander Spira, MD, Alex Spira, MD, PhD, Mitul Gandhi, and Anne Favret, MD.Area of expertise
1Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
EGFR positive
2Solid Tumors
Global LeaderStage IV
Stage III
KRAS positive
Top PIs
Alexander Spira, MDVirginia Cancer Specialists3 years of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Tumors
119 reported clinical trials
161 drugs studied
Alex Spira, MD, PhDNEXT Oncology4 years of reported clinical research
Expert in Solid Tumors
Studies Non-Small Cell Lung Cancer
21 reported clinical trials
32 drugs studied
Mitul GandhiVirginia Cancer Specialists5 years of reported clinical research
Studies Lymphoma
Studies Leukemia
15 reported clinical trials
29 drugs studied
Anne Favret, MDVirginia Cancer Specialists, PC3 years of reported clinical research
Studies Breast Cancer
Studies Tumors
4 reported clinical trials
10 drugs studied
Clinical Trials running at Virginia Cancer Specialists
Non-Small Cell Lung Cancer
Solid Tumors
Tumors
Lung Cancer
Breast Cancer
Prostate Cancer
Cancer
Pancreatic Cancer
Colorectal Cancer
Melanoma
RGX-104 Combination Therapy
for Lung Cancer
Recruiting3 awards Phase 116 criteria
Multiple Therapies
for Stage III Non-Small Cell Lung Cancer
This study will evaluate the efficacy and safety of multiple therapies in participants with locally advanced, unresectable, Stage III NSCLC with eligible biomarker status as determined by Version 8 of the American Joint Committee on Cancer/Union for International Cancer Control NSCLC staging system.
Recruiting2 awards Phase 317 criteria
ONC-392 vs Chemotherapy
for Lung Cancer
The goal of this Phase 3 clinical trial is study the safety and efficacy of the nextgen anti-CTLA-4 antibody, gotistobart (ONC-392/BNT316), in patients with metastatic non-small cell lung cancer who have disease progressed on anti-PD-1/PD-L1 antibody based therapy. The study will test whether gotistobart, in comparison with chemotherapy agent docetaxel, could prolong the life for NSCLC patients. Patients will be randomized to be treated with either gotistobart or docetaxel, IV infusion, once every 21 days, for up to 17 cycles in approximately one year.
Recruiting2 awards Phase 310 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Virginia Cancer Specialists?
Virginia Cancer Specialists is a medical facility located in Fairfax, Virginia. This center is recognized for care of Non-Small Cell Lung Cancer, Solid Tumors, Tumors, Cancer, Lung Cancer and other specialties. Virginia Cancer Specialists is involved with conducting 440 clinical trials across 239 conditions. There are 18 research doctors associated with this hospital, such as Alexander Spira, MD, Alex Spira, MD, PhD, Mitul Gandhi, and Anne Favret, MD.
Where is Virginia Cancer Specialists located?
Virginia Cancer Specialists is located at 8613 Lee Highway, Fairfax, VA 22031.
Who should I call to ask about financial aid or insurance network?
Virginia Cancer Specialists offers comprehensive financial assistance for patients dealing with insurance and billing concerns. Patients can seek help from a Patient Benefit Specialist at their physician's location for insurance inquiries and verifications, or contact Patient Benefits Representatives (PBR) at Virginia Oncology Associates (VOA) locations for guidance on financial issues and assistance programs. For general insurance questions, the insurance coverage page on their website provides a list of accepted insurance companies, with additional coverage options available upon inquiry at the physician's office.
What insurance does Virginia Cancer Specialists accept?
**Virginia Cancer Specialists Insurance Information:**
- Accepts a wide range of insurance plans including but not limited to Aetna US Healthcare, Anthem Blue Cross Blue Shield, Blue Cross Blue Shield North Carolina, CIGNA, Coventry Health Care, and United Healthcare.
- Patients are advised to confirm their insurance plan's participation and be aware of their responsibilities like obtaining referrals and paying copayments, coinsurance, or deductibles.
**Virginia Cancer Institute Insurance Information:**
- Participates with many insurance plans in Central Virginia, with a commitment to staying informed on the changing medical insurance landscape.
- Encourages patients to verify their insurance details and is prepared to assist with insurance queries.
What awards or recognition has Virginia Cancer Specialists received?
Virginia Cancer Specialists (VCS) has been re-accredited for the prestigious Accreditation Program for Excellence (APEx) distinction in 2022, showcasing its excellence in cancer care. It received the Clinical Trials Participation Award in 2016, highlighting its commitment to advancing cancer care through community-based clinical trials. The VCS Research Institute is recognized for its outstanding research program and efficient study start-up timelines.